Smith & Nephew hip implant metallosis lawsuits pass 500 mark

Recalled and defective metal-on-metal hip implants made by Smith & Nephew are now the subject of more than 500 lawsuits pending in state and federal courts. The hip implant lawyers at Jones Ward PLC represent more injured plaintiffs than any other law firm in the nation, and have been involved in litigation since 2013 over… Read More

Invokana gangrene lawsuit filed by Jones Ward

One of the nation’s first diabetes drug lawsuits involving Fournier’s gangrene has been filed in federal court by the pharmaceutical litigation team at Jones Ward PLC. Fournier’s gangrene is a rare disease that affects the genitals and perineum. It is also known as necrotizing fasciitis, and is a type of infection of the genitals or… Read More

Bayer unit tagged with $289 million Roundup cancer verdict

Bayer subsidiary Monsanto faces a $289 million jury verdict over its weedkiller Roundup, which has been linked to cancer. A jury in California found in favor of a retired school groundskeeper who used Roundup as a pesticide for decades. The dying man discovered tumors all over his body, and was diagnosed with in cancer in… Read More

Smith & Nephew Hip Implant Lawsuits Expand

Smith & Nephew Hip Implant Lawsuits Expand

R3 metal liners added to Birmingham Hip Resurfacing litigation A panel of federal judges overseeing hundreds of lawsuits against Smith & Nephew for their failed metal on metal hip devices is expanding the scope of the litigation. The United States Judicial Panel on Multidistrict litigation held that plaintiffs implanted with the recalled R3 metal liner… Read More

MRI risks detailed in new warning for Gadolinium

Gadolinium, a contrast agent used in MRI scans, is the target of a new health warning issued for patients and healthcare providers. The warnings are being added to the medication guide and patient materials for certain MRI, or magnetic resonance imaging tests. Top officials at Bayer, GE, Bracco Diagnostics and Guerbet signed off on the… Read More

Onglyza heart failure lawsuits expand

Onglyza diabetes drug lawsuits are growing in federal court, with the number of claims recently passing the 100 mark. The pharmaceutical legal team at Jones Ward is playing a leading role in these cases. Alex Davis, one of the firm’s partners, filed one of the first Onglyza heart failure lawsuits in federal court in 2016.… Read More